Atectura Breezhaler 80 mcg

ATECTURA BREEZHALER 80 MCG is an inhalation medication containing mometasone furoate, used for managing respiratory conditions. This capsule-based treatment is designed for easy administration via a Breezhaler device.

ATECTURA BREEZHALER 80 MCG is primarily used for the maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD). The active ingredient, mometasone furoate, helps reduce inflammation in the lungs, making it easier to breathe. This medication is often prescribed to manage symptoms such as wheezing, shortness of breath, and coughing associated with these conditions.

Common effects of ATECTURA BREEZHALER 80 MCG may include throat irritation, hoarseness, and a dry mouth. Some users might experience headaches or nasal congestion. These effects are generally mild and temporary, but if they persist or worsen, it is advisable to consult a healthcare provider.

ATECTURA BREEZHALER 80 MCG should be used as directed by a healthcare professional. It is important to follow the prescribed dosage and administration instructions. Patients with a history of severe asthma attacks or other respiratory conditions should use this medication with caution. Always inform your healthcare provider about any other medications you are taking to avoid potential interactions.

ATECTURA BREEZHALER 80 MCG may interact with other medications, including certain antifungal drugs and HIV protease inhibitors. These interactions can affect the effectiveness of mometasone furoate. It is also advisable to avoid alcohol while using this medication, as it may exacerbate some side effects. Always consult a healthcare provider before starting any new medication.